Menu Search
Equities

Top Eminent Healthcare Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6877:HKG.HS

Top Eminent Healthcare Group Ltd

Actions
  • Price (HKD)0.135
  • Today's Change0.00 / 0.00%
  • Shares traded45.00k
  • 1 Year change-12.90%
  • Beta1.8802
Data delayed at least 15 minutes, as of Feb 13 2026 06:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Top Eminent Healthcare Group Ltd, formerly CLSA Premium Ltd, is an investment holding company mainly engaged in the healthcare business. The Company operates its business through two segments. The Healthcare Business segment is engaged in the sale of healthcare products. The Unallocated segment is engaged in the provision of margin trading and services other than healthcare business and the operation of the investment holding company.

  • Revenue in HKD (TTM)92.50m
  • Net income in HKD2.86m
  • Incorporated2010
  • Employees13.00
  • Location
    Top Eminent Healthcare Group LtdSuites 7501 & 7508, 75th FloorInternational Commerce Centre1 Austin Road West, KowloonHong Kong Hong KongHKG
  • Phone+852 21515799
  • Fax+852 34272010
  • Websitehttps://www.tehealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.